The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Sepsis: Inflammation Is a Necessary Evil
Open accessAbstract
Sepsis is one of the leading causes of deaths world-wide and yet there are no therapies available other than ICU treatment. The patient outcome is determined by a complex interplay between the pro and anti-inflammatory responses of the body i.e., a homeostatic balance between these two competing events to be achieved for the patient's recovery. The initial attempts on drug development mainly focused on controlling inflammation, however, without any tangible outcome. This was despite most deaths occurring during the immune paralysis stage of this biphasic disease. Recently, the focus has been shifting to understand immune paralysis (caused by apoptosis and by anti-inflammatory cytokines) to develop therapeutic drugs. In this review we put forth an argument for a proper understanding of the molecular basis of inflammation as well as apoptosis for developing an effective therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Calisto, K. L., Camacho, A. C., Mittestainer, F. C., Carvalho, B. M., Guadagnini, D., Carvalheira, J. B. C., & Saad, M. J. A. (2012) · Critical Care · doi:10.1186/cc11478 · Cited by 20
RetractedBone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Fleischmann, C., Scherag, A., Adhikari, N. K. J., Hartog, C. S., Tsaganos, T., Schlattmann, P., Angus, D. C., & Reinhart, K. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0781oc · Cited by 3,548
Hematological Problems in Pediatric Intensive Care
Revel-Vilk, S., Cox, P., Robitaille, N., & Blanchette, V. (2014) · Pediatric and Adolescent Medicine · doi:10.1159/000350346 · Cited by 3,508
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Mogensen, T. H. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-08 · Cited by 3,111
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448
Taylor, F., Toh, C.-H., Hoots, K., Wada, H., & Levi, M. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616068 · Cited by 2,285
Disseminated Intravascular Coagulation
Levi, M., & ten Cate, H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410807 · Cited by 2,005
Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90807-x · Cited by 1,993
IL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842
Hotchkiss, R. S., Moldawer, L. L., Opal, S. M., Reinhart, K., Turnbull, I. R., & Vincent, J.-L. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.45 · Cited by 1,620
Ziegler, E. J., Fisher, C. J., Sprung, C. L., Straube, R. C., Sadoff, J. C., Foulke, G. E., Wortel, C. H., Fink, M. P., Dellinger, R. P., Teng, N. N. H., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102143240701 · Cited by 1,611
Signaling in innate immunity and inflammation
Newton, K., & Dixit, V. M. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006049 · Cited by 1,513 · cited 1×
“When homeostasis is maintained, excessive inflammation and immune cell activity is avoided, and the immune system can prime itself for effective response to future infection (Newton and Dixit, 2012).”
BackgroundHigh-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial
Warren, B. L., Eid, A., Singer, P., Pillay, S. S., Carl, P., Novak, I., Chalupa, P., Atherstone, A., Pénzes, I., Kübler, A., et al. (2001) · JAMA · doi:10.1001/jama.286.15.1869 · Cited by 1,419
Multiple-Organ Failure: Generalized Autodestructive Inflammation?
Goris, R. J. A. (1985) · Archives of Surgery · doi:10.1001/archsurg.1985.01390340007001 · Cited by 1,289
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H., & Benjamin, E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342603 · Cited by 1,241
Mayr, F. B., Yende, S., & Angus, D. C. (2014) · Virulence · doi:10.4161/viru.27372 · Cited by 1,208
Hayden, M. S., West, A. P., & Ghosh, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209943 · Cited by 1,178
Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
Sha, W. C., Liou, H.-C., Tuomanen, E. I., & Baltimore, D. (1995) · Cell · doi:10.1016/0092-8674(95)90415-8 · Cited by 1,157
Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a Mutant Escherichia coli
Ziegler, E. J., McCutchan, J. A., Fierer, J., Glauser, M. P., Sadoff, J. C., Douglas, H., & Braude, A. I. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211113072001 · Cited by 1,046
Adjunctive glucocorticoid therapy in patients with septic shock.
Venkatesh, B., Finfer, S., Cohen, J., Rajbhandari, D., Arabi, Y., Bellomo, R., Billot, L., Correa, M., Glass, P., Harward, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705835 · Cited by 1,037
ROLE OF C5A IN INFLAMMATORY RESPONSES
Guo, R.-F., & Ward, P. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115835 · Cited by 1,021
Treating Patients with Severe Sepsis
Wheeler, A. P., & Bernard, G. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400307 · Cited by 992
Levi, M., & van der Poll, T. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c98d21 · Cited by 984
Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death
Abraham, E., Laterre, P.-F., Garg, R., Levy, H., Talwar, D., Trzaskoma, B. L., François, B., Guy, J. S., Brückmann, M., Rea-Neto, Á., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050935 · Cited by 890
Levy, M. M., Dellinger, R. P., Townsend, S. R., Linde-Zwirble, W. T., Marshall, J. C., Bion, J., Schorr, C., Artigas, A., Ramsay, G., Beale, R., et al. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1738-3 · Cited by 868
Animal Models of sepsis: setting the stage
Buras, J. A., Holzmann, B., & Sitkovsky, M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1854 · Cited by 843
The Effects of Ibuprofen on the Physiology and Survival of Patients with Sepsis
Bernard, G. R., Wheeler, A. P., Russell, J. A., Schein, R., Summer, W. R., Steinberg, K. P., Fulkerson, W. J., Wright, P. E., Christman, B. W., Dupont, W. D., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703273361303 · Cited by 837
Opal, S. M., Laterre, P.-F., Francois, B., LaRosa, S. P., Angus, D. C., Mira, J.-P., Wittebole, X., Dugernier, T., Perrotin, D., Tidswell, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.2194 · Cited by 812
Gentile, L. F., Cuenca, A. G., Efron, P. A., Ang, D., Bihorac, A., McKinley, B. A., Moldawer, L. L., & Moore, F. A. (2012) · Journal of Trauma and Acute Care Surgery · doi:10.1097/ta.0b013e318256e000 · Cited by 801
Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View
Schulte, W., Bernhagen, J., & Bucala, R. (2013) · Mediators of Inflammation · doi:10.1155/2013/165974 · Cited by 745
Protection from septic shock by neutralization of macrophage migration inhibitory factor
Calandra, T., Echtenacher, B., Roy, D. L., Pugin, J., Metz, C. N., Hültner, L., Heumann, D., Männel, D., Bucala, R., & Glauser, M. P. (2000) · Nature Medicine · doi:10.1038/72262 · Cited by 723
Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group.
Bone, R. C., Fisher, C. J., Clemmer, T. P., Gj, S., METZ, C. A., & BALK, R. A. (1989) · PubMed · Cited by 689
Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes
Martin, G. S. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.50 · Cited by 680
Meisel, C., Schefold, J. C., Pschowski, R., Baumann, T., Hetzger, K., Gregor, J., Weber-Carstens, S., Hasper, D., Keh, D., Zuckermann, H., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0363oc · Cited by 648
Psychiatric Adverse Effects of Corticosteroids
Warrington, T. P., & Bostwick, J. M. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.10.1361 · Cited by 611
Has the mortality of septic shock changed with time?
Friedman, G., Silva, E., & Vincent, J.-L. (1998) · Critical Care Medicine · doi:10.1097/00003246-199812000-00045 · Cited by 607
Disseminated intravascular coagulation
Gando, S., Levi, M., & Toh, C.-H. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.37 · Cited by 572
Host–pathogen interactions in sepsis
van der Poll, T., & Opal, S. M. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70265-7 · Cited by 553
Steroids in the Treatment of Clinical Septic Shock
SCHUMER, W. (1976) · Annals of Surgery · doi:10.1097/00000658-197609000-00011 · Cited by 545
Sepsis syndrome: A valid clinical entity
BONE, R. C., FISHER, C. J., CLEMMER, T. P., SLOTMAN, G. J., METZ, C. A., & BALK, R. A. (1989) · Critical Care Medicine · doi:10.1097/00003246-198905000-00002 · Cited by 537
Huang, X., Venet, F., Wang, Y. L., Lepape, A., Yuan, Z., Chen, Y., Swan, R., Kherouf, H., Monneret, G., Chung, C.-S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809422106 · Cited by 515
Persistent Lymphopenia After Diagnosis of Sepsis Predicts Mortality
Drewry, A. M., Samra, N., Skrupky, L. P., Fuller, B. M., Compton, S. M., & Hotchkiss, R. S. (2014) · Shock · doi:10.1097/shk.0000000000000234 · Cited by 512
Effects of a nitric oxide synthase inhibitor in humans with septic shock
Petros, A., Lamb, G., Leone, A., Moncada, S., Bennett, D., & Vallance, P. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.1.34 · Cited by 509
McCloskey, R. V., Straube, R. C., Sanders, C., Smith, S. M., Smith, C. R., & and CHESS Trial Study Group. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-1-199407010-00001 · Cited by 495
Prevention of lymphocyte cell death in sepsis improves survival in mice
Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Chang, K. C., Cobb, J. P., Buchman, T. G., Korsmeyer, S. J., & Karl, I. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14541 · Cited by 454
The late phase of sepsis is characterized by an increased microbiological burden and death rate
Otto, G. P., Sossdorf, M., Claus, R. A., Rödel, J., Menge, K., Reinhart, K., Bauer, M., & Riedemann, N. C. (2011) · Critical Care · doi:10.1186/cc10332 · Cited by 434
Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial
Francois, B., Jeannet, R., Daix, T., Walton, A. H., Shotwell, M. S., Unsinger, J., Monneret, G., Rimmelé, T., Blood, T., Morre, M., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98960 · Cited by 431
Bakhtiari, K., Meijers, J. C. M., de Jonge, E., & Levi, M. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000147769.07699.e3 · Cited by 423
Reactivation of Multiple Viruses in Patients with Sepsis
Walton, A. H., Muenzer, J. T., Rasche, D., Boomer, J. S., Sato, B., Brownstein, B. H., Pachot, A., Brooks, T. L., Deych, E., Shannon, W. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098819 · Cited by 411
The ABDOMIX Group, Payen, D. M., Guilhot, J., Launey, Y., Lukaszewicz, A. C., Kaaki, M., Veber, B., Pottecher, J., Joannes-Boyau, O., Martin-Lefevre, L., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3751-z · Cited by 407
Fink, M. P. (2014) · Virulence · doi:10.4161/viru.26083 · Cited by 391
Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
Johnston, J. A., Bacon, C. M., Finbloom, D. S., Rees, R. C., Kaplan, D., Shibuya, K., Ortaldo, J. R., Gupta, S., Chen, Y. Q., & Giri, J. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8705 · Cited by 390
Overexpression of Bcl-2 in Transgenic Mice Decreases Apoptosis and Improves Survival in Sepsis
Hotchkiss, R. S., Swanson, P. E., Knudson, C. M., Chang, K. C., Cobb, J. P., Osborne, D. F., Zollner, K. M., Buchman, T. G., Korsmeyer, S. J., & Karl, I. E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4148 · Cited by 381
Zimmerman, G. A., McIntyre, T. M., Prescott, S. M., & Stafforini, D. M. (2002) · Critical Care Medicine · doi:10.1097/00003246-200205001-00020 · Cited by 358
Activation of NF-kappa B in vivo is regulated by multiple phosphorylations.
Naumann, M., & Scheidereit, C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06781.x · Cited by 352
Borrelli, E., Roux-Lombard, P., Grau, G. E., Girardin, E., Ricou, B., Dayer, J.-M., & Suter, P. M. (1996) · Critical Care Medicine · doi:10.1097/00003246-199603000-00006 · Cited by 349
Accelerated Lymphocyte Death in Sepsis Occurs by both the Death Receptor and Mitochondrial Pathways
Hotchkiss, R. S., Osmon, S. B., Chang, K. C., Wagner, T. H., Coopersmith, C. M., & Karl, I. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.5110 · Cited by 343
Vincent, J.-L., Bernard, G. R., Beale, R., Doig, C., Putensen, C., Dhainaut, J.-F., Artigas, A., Fumagalli, R., Macias, W., Wright, T., et al. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000181729.46010.83 · Cited by 318
Current Murine Models of Sepsis
Lewis, A. J., Seymour, C. W., & Rosengart, M. R. (2016) · Surgical Infections · doi:10.1089/sur.2016.021 · Cited by 303
Landelle, C., Lepape, A., Voirin, N., Tognet, E., Venet, F., Bohé, J., Vanhems, P., & Monneret, G. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1962-x · Cited by 296
The function of neutrophils in sepsis
Kovach, M. A., & Standiford, T. J. (2012) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283528c9b · Cited by 293
Zhong, W., Qian, K., Xiong, J., Ma, K., Wang, A., & Zou, Y. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.06.036 · Cited by 274
Corticosteroids in Sepsis: An Updated Systematic Review and Meta-Analysis
Rochwerg, B., Oczkowski, S. J., Siemieniuk, R. A. C., Agoritsas, T., Belley-Cote, E., D’Aragon, F., Duan, E., English, S., Gossack-Keenan, K., Alghuroba, M., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003262 · Cited by 258
Macroscopic Postmortem Findings in 235 Surgical Intensive Care Patients with Sepsis
Torgersen, C., Moser, P., Luckner, G., Mayr, V., Jochberger, S., Hasibeder, W. R., & Dünser, M. W. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318195e11d · Cited by 254
Clinical use of anti-TNF therapy and increased risk of infections
Ali, T., Bronze, Kaitha, Mahmood, Ftaisi, & Stone (2013) · Drug, Healthcare and Patient Safety · doi:10.2147/dhps.s28801 · Cited by 242
Melby, J. C., & Spink, W. W. (1958) · Journal of Clinical Investigation · doi:10.1172/jci103772 · Cited by 237
Timing and causes of death in septic shock
Daviaud, F., Grimaldi, D., Dechartres, A., Charpentier, J., Geri, G., Marin, N., Chiche, J.-D., Cariou, A., Mira, J.-P., & Pène, F. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0058-8 · Cited by 234
Patera, A. C., Drewry, A. M., Chang, K., Beiter, E. R., Osborne, D., & Hotchkiss, R. S. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4hi0616-255r · Cited by 217
The Primary Role of Lymphoreticnlar Cells in the Mediation of Host Responses to Bacterial Endotoxim
Michalek, S. M., Moore, R. N., McGhee, J. R., Rosenstreich, D. L., & Mergenhagen, S. E. (1980) · Journal of Infectious Diseases · doi:10.1093/infdis/141.1.55 · Cited by 210
Marked alterations of neutrophil functions during sepsis-induced immunosuppression
Demaret, J., Venet, F., Friggeri, A., Cazalis, M.-A., Plassais, J., Jallades, L., Malcus, C., Poitevin-Later, F., Textoris, J., Lepape, A., et al. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4a0415-168rr · Cited by 205
Adverse functions of IL‐17A in experimental sepsis
Flierl, M. A., Rittirsch, D., Gao, H., Hoesel, L. M., Nadeau, B. A., Day, D. E., Zetoune, F. S., Sarma, J. V., Huber-Lang, M. S., Ferrara, J. L. M., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-105221 · Cited by 203
Sprung, C. L., Sakr, Y., Vincent, J.-L., Le Gall, J.-R., Reinhart, K., Ranieri, V. M., Gerlach, H., Fielden, J., Groba, C. B., & Payen, D. (2006) · Intensive Care Medicine · doi:10.1007/s00134-005-0039-8 · Cited by 201
Escoll, P., del Fresno, C., Garcı́a, L., Vallés, G., Lendı́nez, M. J., Arnalich, F., & López-Collazo, E. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.019 · Cited by 199
Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study)*
Jaimes, F., De La Rosa, G., Morales, C., Fortich, F., Arango, C., Aguirre, D., & Muñoz, Á. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819c06bc · Cited by 194
Sepsis and Septic Shock: Current Treatment Strategies and New Approaches
Halici, Z., Cadirci, E., Polat, G., & Ugan, R. A. (2019) · The Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2017.17062 · Cited by 192
Long-term outcome and quality-adjusted life years after severe sepsis*
Karlsson, S., Ruokonen, E., Varpula, T., Ala-Kokko, T. I., & Pettilä, V. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819c13ac · Cited by 174
Vincent, J.-L., & Abraham, E. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1604oe · Cited by 167
Tinsley, K. W., Grayson, M. H., Swanson, P. E., Drewry, A. M., Chang, K. C., Karl, I. E., & Hotchkiss, R. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.909 · Cited by 167
The Harmful Role of C5a on Innate Immunity in Sepsis
Ward, P. A. (2010) · Journal of Innate Immunity · doi:10.1159/000317194 · Cited by 159
Innate Immune Function and Mortality in Critically Ill Children With Influenza
Hall, M. W., Geyer, S. M., Guo, C., Panoskaltsis‐Mortari, A., Jouvet, P. A., Ferdinands, J. M., Shay, D. K., Nateri, J., Greathouse, K. C., Sullivan, R., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318267633c · Cited by 154
Grimaldi, D., Louis, S., Pène, F., Sirgo, G., Rousseau, C., Claessens, Y.-É., Vimeux, L., Cariou, A., Mira, J. P., Hosmalin, A., et al. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2306-1 · Cited by 153
RODENT MODELS OF INTRA-ABDOMINAL INFECTION
Deitch, E. A. (2005) · Shock · doi:10.1097/01.shk.0000191386.18818.0a · Cited by 141
Patel, J. M., Snaith, C., THICKETT, D. R., Linhartova, L., Melody, T., Hawkey, P. M., Barnett, A. H., Jones, A. F., Hong, T., Cooke, M. W., et al. (2012) · Critical Care · doi:10.1186/cc11895 · Cited by 137
Complexity of complement activation in sepsis
Markiewski, M. M., DeAngelis, R. A., & Lambris, J. D. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00504.x · Cited by 133
Caspase-8 Collaborates with Caspase-11 to Drive Tissue Damage and Execution of Endotoxic Shock
Mandal, P., Feng, Y., Lyons, J. D., Berger, S. B., Otani, S., DeLaney, A. A., Tharp, G. K., Maner-Smith, K. M., Burd, E. M., Schaeffer, M. C., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.06.011 · Cited by 133
A Review of GM-CSF Therapy in Sepsis
Mathias, B. J., Szpila, B. E., Moore, F. A., Efron, P. A., & Moldawer, L. L. (2015) · Medicine · doi:10.1097/md.0000000000002044 · Cited by 123
THE EPIDEMIOLOGY OF BACTERIAL SEPSIS
Rangel-Frausto, M. S. (1999) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70076-3 · Cited by 119
Platelet activation and antiplatelet therapy in sepsis: A narrative review
Wang, Y., Ouyang, Y., Liu, B., Ma, X., & Ding, R. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.04.007 · Cited by 118
Sepsis and Other Infectious Disease Emergencies in the Elderly
Liang, S. Y. (2016) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2016.04.005 · Cited by 115
High Susceptibility of Strain A Mice to Endotoxin and Endotoxin-Red Blood Cell Mixtures
Heppner, G. H., & Weiss, D. W. (1965) · Journal of Bacteriology · doi:10.1128/jb.90.3.696-703.1965 · Cited by 105
Weighardt, H., Heidecke, C.-D., Emmanuilidis, K., Maier, S., Bartels, H., Siewert, J., & Holzmann, B. (2000) · Surgery · doi:10.1067/msy.2000.104118 · Cited by 103
Echtenacher, B., Weigl, K., Lehn, N., & Männel, D. N. (2001) · Infection and Immunity · doi:10.1128/iai.69.6.3550-3555.2001 · Cited by 96
Esmon, C. T. (2003) · Journal of Endotoxin Research · doi:10.1179/096805103125001603 · Cited by 94
Shindo, Y., Unsinger, J., Burnham, C.-A., Green, J. M., & Hotchkiss, R. S. (2015) · Shock · doi:10.1097/shk.0000000000000317 · Cited by 92
Danger signals from mitochondrial DAMPS in trauma and post-injury sepsis
Hauser, C. J., & Otterbein, L. E. (2018) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-018-0963-2 · Cited by 91
Cytokines in innate and adaptive immunity.
Banyer, J., Hamilton, N. H. R., Ramshaw, I. A., & Ramsay, A. J. (2000) · PubMed · Cited by 88
Phenotype and Functions of Natural Killer Cells in Critically-Ill Septic Patients
Forel, J.-M., Chiche, L., Thomas, G., Mancini, J., Farnarier, C., Cognet, C., Guervilly, C., Daumas, A., Vely, F., Xeridat, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050446 · Cited by 86
Bunnell, E., Lynn, M., Habet, K. J., Neumann, A., Perdomo, C. A., Friedhoff, L. T., Rogers, S. L., & Parrillo, J. E. (2000) · Critical Care Medicine · doi:10.1097/00003246-200008000-00005 · Cited by 85
Reinhart, K., Glück, T., Ligtenberg, J. J. M., Tschaikowsky, K., Bruining, A., Bakker, J., Opal, S. M., Moldawer, L. L., Axtelle, T., Turner, T., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000124870.42312.c4 · Cited by 80
Immunoinflammatory Response in Critically Ill Patients: Severe Sepsis and/or Trauma
Šurbatović, M., Veljović, M., Jevdjic, J., Popović, N., Djordjevic, D., & Radakovic, S. (2013) · Mediators of Inflammation · doi:10.1155/2013/362793 · Cited by 74
Condotta, S. A., Khan, S. H., Rai, D., Griffith, T. S., & Badovinac, V. P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402473 · Cited by 69
The Central Role of the Inflammatory Response in Understanding the Heterogeneity of Sepsis-3
Ding, R., Meng, Y., & Ma, X. (2018) · BioMed Research International · doi:10.1155/2018/5086516 · Cited by 68
The complex link between influenza and severe sepsis
Florescu, D. F., & Kalil, A. C. (2013) · Virulence · doi:10.4161/viru.27103 · Cited by 67
Helminths and their implication in sepsis - a new branch of their immunomodulatory behaviour?
Hübner, M. P., Layland, L. E., & Hoerauf, A. M. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12080 · Cited by 61
Prabhakar, U., Conway, T. M., Murdock, P. R., Mooney, J. L., Clark, S., Hedge, P., Bond, B. C., Jazwinska, E. C., Barnes, M. R., Tobin, F. L., et al. (2005) · DNA and Cell Biology · doi:10.1089/dna.2005.24.410 · Cited by 55
MODULATION OF THE BCL-2 FAMILY BLOCKS SEPSIS-INDUCED DEPLETION OF DENDRITIC CELLS AND MACROPHAGES
Peck‐Palmer, O. M., Unsinger, J., Chang, K. C., McDonough, J. S., Perlman, H., McDunn, J. E., & Hotchkiss, R. S. (2009) · Shock · doi:10.1097/shk.0b013e31818ba2a2 · Cited by 52
VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis
Weber, P., Wang, P., Maddens, S., Wang, P. S., Wu, R., Miksa, M., Dong, W., Mortimore, M., Golec, J. M. C., & Charlton, P. (2009) · Critical Care · doi:10.1186/cc8041 · Cited by 48
Immunoadjuvant therapy in sepsis: novel strategies for immunosuppressive sepsis coming down the pike
Watanabe, E., Thampy, L. K., & Hotchkiss, R. S. (2018) · Acute Medicine & Surgery · doi:10.1002/ams2.363 · Cited by 41
Sakr, Y. L., Maia, V. P., Santos, C., Stracke, J., Zeidan, M. A., Bayer, O., & Reinhart, K. (2014) · Critical Care · doi:10.1186/cc13825 · Cited by 40
Is There a Role for Hematopoietic Growth Factors During Sepsis?
Chousterman, B. G., & Arnaud, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01015 · Cited by 39
Sepsis and Septic Shock: Pro-Inflammatory or Anti-Inflammatory State?
Antonelli, M. M. (1999) · Journal of Chemotherapy · doi:10.1179/joc.1999.11.6.536 · Cited by 36
A double-blind study of the effectiveness of cortisol in the management of severe infections.
BENNETT, I. L., Finland, M., Hamburger, M., et al. (1962) · PubMed · Cited by 28
Colling, K. P., Banton, K. L., & Beilman, G. J. (2018) · Surgical Infections · doi:10.1089/sur.2017.255 · Cited by 26
O ônus da sepse: uma chamada em apoio ao Dia Mundial da Sepse 2013
Reinhart, K., Daniels, R., & Machado, F. R. (2013) · Revista Brasileira de Terapia Intensiva · doi:10.1590/s0103-507x2013000100002 · Cited by 25
Impact of transcription factors AP-1 and NF-κB on the outcome of experimental arthritis and sepsis
Gjertsson, I., Hultgren, O., Collins, L. V., Pettersson, S., & Tarkowski, A. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01408-3 · Cited by 23
In Search of a Cure for Sepsis: Taming the Monster in Critical Care Medicine
Okeke, E. B., & Uzonna, J. E. (2016) · Journal of Innate Immunity · doi:10.1159/000442469 · Cited by 23
The rise and fall of infectious diseases: Australian perspectives, 1914‐2014
Cossart, Y. E. (2014) · The Medical Journal of Australia · doi:10.5694/mja14.00112 · Cited by 19
McKechnie, K. C. W., Furman, B. L., & Parratt, J. R. (1985) · PubMed · Cited by 16
Unveiling differentially expressed genes upon regulation of transcription factors in sepsis
Zhang, J., Cheng, Y., Duan, M., Qi, N., & Liu, J. (2017) · 3 Biotech · doi:10.1007/s13205-017-0713-x · Cited by 15
The quest for the optimal blood pressure in septic shock
Dhooria, S., Sehgal, I. S., & Agarwal, R. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.08.27 · Cited by 4
Cited by
Gan, B. H., Gaynord, J., Rowe, S. M., Deingruber, T., & Spring, D. R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00729c · Cited by 511
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
Mifflin, L., Ofengeim, D., & Yuan, J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0071-y · Cited by 479
A flexible multiplexed immunosensor for point-of-care in situ wound monitoring
Gao, Y., Nguyen, D. T., Yeo, T., Lim, S. B., Tan, W. X., Madden, L. E., Jin, L., Long, J. Y. K., Aloweni, F. A. B., Liew, Y. J. A., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg9614 · Cited by 283
Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis
Nedeva, C. (2021) · Biomolecules · doi:10.3390/biom11071011 · Cited by 265
Self-citationSepsis-Associated Encephalopathy: from Pathophysiology to Progress in Experimental Studies
Catarina, A. V., Branchini, G., Bettoni, L., De Oliveira, J. R., & Nunes, F. B. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02303-2 · Cited by 155
Metadata
- Authors
- Nedeva, C., Menassa, J., & Puthalakath, H.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2019-06-20
- Volume
- 7
- Pages
- 108-108
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W2952073233
- Cited by
- 301
- References
- 132
- FWCI
- 20.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.